Abstract:Mutations of the cardiac β-myosin heavy-chain (β-MHC) gene cause hypertrophic cardiomyopathy (HCM). Recent genotype–phenotype correlation studies have shown that mutations carry prognostic significance. We studied five unrelated Chinese families with hypertrophic cardiomyopathy. Exons 3–27 and 40 of the β-MHC gene were screened with both the polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) method and the cycle sequencing of the PCR products. A previously reported heterozygous mutation Arg719Gln (arginine→glutamine in codon 719) in exon 19 was found in one family. The proband is a 30-year-old female diagnosed at age of 25 years when she presented with symptoms of chest pain, palpitations, and frequent incidents of dizziness and syncope. A two-dimensional echocardiogram showed moderate asymmetrical septal hypertrophy with left atrial enlargement. There was no obstruction of the left ventricular outflow tract (LVOT). The patient also developed atrial fibrillation. The proband's mother and one of her sisters had similar clinical manifestations and both died suddenly at the age of 38 years. In addition, two silent nucleotide substitutions (ACT63ACC, TTT244TTC) in the cardiac β-MHC gene were identified in the other four families. These synonymous mutations did not cosegregate with the disease in the families and they were also present in the 60 healthy and age-matched control subjects. Of the five families studied, we did not find any missense mutation in the remaining four families. The missense mutation Arg719Gln found in the Chinese family is associated with a malignant phenotype of severe clinical symptoms and poor survival prognosis. This mutation also causes atrial enlargement and atrial fibrillation. Our study provides further evidence that the mutation, which alters the charge of the myosin heavy chain, is associated with a serious clinical outcome.

Mutations of the β-myosin heavy chain and troponin T genes in sporadic hypertrophic cardiomyopathy

Characteristics of the beta myosin heavy chain gene Ala26Val mutation in a Chinese family with hypertrophic cardiomyopathy.

[Comparative Study of Gene Mutation Between Chinese Patients with Familial and Sporadic Hypertrophic Cardiomyopathy].

[Advances in the Molecular Pathogenesis of Hypertrophic Cardiomyopathy].

The Novel Mitochondrial 16S Rrna 2336T>C Mutation is Associated with Hypertrophic Cardiomyopathy

[Analysis of MYH7, MYBPC3 and TNNT2 Gene Mutations in 10 Chinese Pedigrees with Familial Hypertrophic Cardiomyopathy and the Correlation Between Genotype and Phenotype].

Correlation of Cardiac Troponin T Gene Mutations to Hypertrophic Cardiomyopathy in Chinese Patients

Mutation screening of MYH7 gene in a chinese pedigree with familial hypertrophic cardiomyopathy

Analysis of 18 and 20 exons mutation in MYH7 gene between patients with sporadic and familial hypertrophic cardiomyopathy in Anhui

Mutation spectrum in a large cohort of unrelated Chinese patients with hypertrophic cardiomyopathy.

[Novel Mutations of Cardiac Troponin T in Chinese Patients with Hypertrophic Cardiomyopathy].

Mutation Analysis of the Small Heat Shock Protein 27 Gene in Chinese Patients with Charcot-Marie-Tooth Disease

GW24-e1791 Mutation spectrum in a large cohort of unrelated Chinese patients with hypertrophic cardiomyopathy

[Mutations in Beta Myosin Heavy Chain Gene: Two Mutations in Chinese with Familial Hypertrophic Cardiomyopathy and the Correlation Between the Genotype and Phenotype].

[Link between cardiac myosin binding protein-C gene mutation of Pro1208fs and Gly507 Arg and hypertrophic cardiomyopathy in Chinese patients].

[Mutation and Clinical Relevance in a Large Cohort of Unrelated Chinese Patients with Hypertrophic Cardiomyopathy].

MYH7 Gene-Related Mutation P.v878l Identified in a Chinese Family with Hypertrophic Cardiomyopathy.

Worse Prognosis With Gene Mutations Of Beta-Myosin Heavy Chain Than Myosin-Binding Protein C In Chinese Patients With Hypertrophic Cardiomyopathy

Familial Hypertrophic Cardiomyopathy and Troponin T

Exome Sequencing Identifies a Novel MYH7 P.g407c Mutation Responsible for Familial Hypertrophic Cardiomyopathy

A malignant phenotype of hypertrophic cardiomyopathy caused by Arg719Gln cardiac beta-myosin heavy-chain mutation in a Chinese family.